BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management
Completed
Arena Pharmaceuticals
Phase 3
2006-11-01
The purpose of this study is to assess the weight loss effect of lorcaserin at the end of the
first year of treatment (Week 52) and to assess the ability of lorcaserin to maintain weight
loss at the end of the second year of treatment (Week 104)
BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management
Completed
Eisai Inc.
Phase 3
2006-11-01
The purpose of this study is to assess the weight loss effect of lorcaserin at the end of the
first year of treatment (Week 52) and to assess the ability of lorcaserin to maintain weight
loss at the end of the second year of treatment (Week 104)
BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus
Completed
Arena Pharmaceuticals
Phase 3
2007-12-01
The purpose of this study is to assess the weight loss effect of lorcaserin during and at the
end of 1 year of treatment in overweight and obese patients with Type II diabetes mellitus
treated with metformin, sulfonylurea (SFU), or either agent in combination with other oral
hypoglycemic agents.
BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus
Completed
Eisai Inc.
Phase 3
2007-12-01
The purpose of this study is to assess the weight loss effect of lorcaserin during and at the
end of 1 year of treatment in overweight and obese patients with Type II diabetes mellitus
treated with metformin, sulfonylurea (SFU), or either agent in combination with other oral
hypoglycemic agents.
BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity Management
Completed
Arena Pharmaceuticals
Phase 3
2008-01-01
The purpose of this study is to assess the weight loss effect of lorcaserin during and at the
end of 1 year of treatment in overweight and obese patients.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
